Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
| Image |  |
|---|---|
| Description | scientific article published on 14 August 2017 |
| Author/s |
author: Robert Lambkin-Williams Mauricio Maia |
| Publication date | October 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |